Bioxytran Inc BIXT
Trading Information
- Previous Close Price
- $0.02
- Day Range
- $0.02–0.02
- 52-Week Range
- $0.02–0.09
- Bid/Ask
- $0.02 / $0.03
- Shares Outstanding
- 114.70M
- Market Cap
- $2.53M
- Volume/Avg
- 65,110 / 93,047
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Bioxytran Inc is a clinical stage pharmaceutical company developing platform technologies in the fields of Glycovirology, Hypoxia and Degenerative Diseases to eliminate viruses and prolong lifespan using carbohydrate drug design. Bioxytran uses Galectin inhibitors to combat the virus, SARS-CoV-2. Glycovirology is a novel glycan-based platform technology. The concept involves using sugar-based drugs to block viruses. The company is developing an inventive platform of oxygen therapeutic treatments for hypoxic conditions and necrosis prevention.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 3
- Website
- https://www.bioxytraninc.com
Valuation
|
Metric
|
BIXT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
BIXT
Financial Strength
|
Metric
|
BIXT
|
|---|---|
Quick Ratio | 0.03 |
Current Ratio | 0.03 |
Interest Coverage | −13.80 |
Quick Ratio
BIXT
Profitability
|
Metric
|
BIXT
|
|---|---|
Return on Assets (Normalized) | −648.72% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
BIXT
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|P^%<Z%> | LOCK|&!Mw> | $128B | |||
| Moderna Inc
MRNA
| LOCK|N$nJ$< | LOCK|$J@ | $81B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|Q&lR^gp | LOCK|PMq@! | $75B | |||
| argenx SE ADR
ARGX
| LOCK|$&cMBp | LOCK|!^# | $57B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|x$CzkVZ | LOCK|j>R | $43B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|Q%>&qgw | LOCK|Wf!V! | $29B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|MV&s%X& | LOCK|L?Sz | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|qHDk%Z | LOCK|?m@ | $25B | |||
| Incyte Corp
INCY
| LOCK|^FY>vjL | LOCK|W!M | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|Z^xCr&k | LOCK|T< | $15B |
United States